1274493

Keila Hoover, M.D. — FEI 3016483191

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)